HomeresearchPeptides

Peptides

-

Contents of this longer article:

Peptides as a “Game Changer” in Medicine

  • Dr. Adel Rayess’s Note,
  • Legal Situation,
  • Studies on Interstitial Cystitis or Eye Injury,
  • Alcohol-Related Intestinal Damage or
  • Leaky Gut or
  • Liver Cirrhosis
  • Semax in Stroke
  • Bone Injuries
  • @HealthyAlfred
  • Neurotropic Peptides – AI-Research of Pubmed
  • Superstars from the USA are all using it

All with links to the original studies or tweets, as well as the corresponding YouTube interviews

 

 

Adel tells me about “miracles” in his practice

My colleague from Lebanon, Dr. Adel Rayess, made me aware of peptides (especially BPC-157 and TB-500).

Dr. Rayess uses the peptides with great success and calls them a game-changer in his practice.

As an osteopathic physician and inventor of NeuroSPINE, he treats many very serious patients who have often been ill for many years and undergone multiple prior treatments (see the video testimonials).

His personal statements are:

“In cases of severe injuries, even those with long-standing recurrences, including severe herniated discs—just two applications three weeks apart were a game-changer.”

This evidence, significance, and relevance resonates with me!

 

Peptides banned as doping agents in sports due to their extreme healing support

Peptides banned in competitive sports due to their ability to accelerate healing

Peptides in sports – legal situation

Many peptides are clearly banned in competitive sports.

The authoritative reference is the World Anti-Doping Agency (WADA) list, which is updated annually and applies worldwide to organized sports.

 

Which peptides are affected

WADA lists peptides under the category:

  • S2: Peptide hormones, growth factors and related substances
  • Growth hormones and their fragments
  • IGF-1 and related factors
  • Erythropoietin (EPO)
  • as well as numerous synthetic or experimental peptides

Substances such as:

  • BPC-157
  • TB-500 (Thymosin Beta-4 Derivatives)

are also used in practice as classified as prohibited because they:

  • accelerate regenerative processes
  • potentially enhance performance
  • and are not permitted

Reason for the prohibition

Peptides are prohibited in sports if they meet at least one of the following criteria:

    • performance enhancement (e.g., faster regeneration, muscle growth)
    • health risk
    • violation of the “Spirit of Sport”

This is especially true for BPC-157 and TB-500

      • massive acceleration of Healing processes
      • faster return after injuries

Important addition

      • The ban applies to competitive sports and organized performance sports
      • In recreational sports there is no direct “prosecution”, but:
      • application remains legally problematic
      • and medically not approved

Conclusion

Peptides such as BPC-157 and TB-500 are:

      • banned in competitive sports (doping list)
      • not medically approved
      • and are currently in the realm of experimental or unregulated use

 

 

Legal status of peptides in medical practice

The use of peptides such as BPC-157 and TB-500 in medical practice is clearly restricted by law and is currently not permitted.

Legal approval status not granted = prohibited

 

Approval status in the EU

      • No approval as a medicinal product in the European Union
      • Neither approved by the European Medicines Agency nor national authorities
      • Therefore, no legal marketing or prescription as a medicine
      • No regular use on patients permitted
      • Not used as part of standard therapy
      • Not billable as a medical service

Off-Label vs. “Not Approved”

Important legal distinction:

      • Off-Label Use = approved medication, but for a different indication → permitted under certain conditions
      • BPC-157 / TB-500 = not approved → does not fall under off-label use

The use of such substances is not a classic gray area, but rather lies clearly outside the scope of regular medical freedom of therapy.

I do know colleagues in the EU who use these peptides. Unfortunately, this is not currently possible for us! The rationale comes primarily from competitive sports: a massive acceleration of the healing of (even old) injuries (see examples below).

Studies

What I find particularly impressive, however, are the various tweets I regularly receive about peptides, which showcase both human and animal studies with their enormous healing-enhancing data.

Interstitial cystitis is torture!!!!!

Many women simply have their bladder surgically removed. I’ve discovered that this is MCAS (Multiple Chemical Sensitivity) and that it can be treated quite effectively with appropriate treatments and a histamine-free diet.

With a short course of BPC-157, the symptoms disappeared within two weeks in 80% of patients, and in the remaining 20%, the symptoms improved by 80%!

BPC-157 in Interstitial Cystitis - Clinical Study

BPC-157 in Interstitial Cystitis – Clinical Study

In a small clinical pilot study, the use of BPC-157 in patients with interstitial cystitis – a chronic bladder inflammation often characterized by severe pain, urinary urgency, and a significant reduction in quality of life.

All participating patients had previously received established therapies without sufficient success.

BPC-157 in Interstitial Cystitis – Clinical Study

In a small clinical pilot study, the use of BPC-157 in patients with interstitial cystitis – a chronic bladder inflammation often accompanied by severe pain, urinary urgency, and a significant reduction in quality of life – was investigated.

All participating patients had previously received established therapies without sufficient success. The results of this study are remarkable:

        • 10 out of 12 patients reported complete relief from symptoms
        • 2 out of 12 showed a significant improvement (approximately 80%)
        • The effect occurred rapidly, within about 2 weeks
        • No side effects were reported

A clear change was also objectively observed during cystoscopy:

… Regeneration of the urothelium (bladder lining)

The combination of rapid onset of action and structurally visible healing in the tissue is particularly striking.

Original study: PMID: 39325560 – Title: BPC-157 in interstitial cystitis – pilot clinical study (2024) (PubMed): https://pubmed.ncbi.nlm.nih.gov/39325560/

BPC-157 for Knee Pain – Study Summary

A very sloppy study, using only “knee pain” as a criterion with a ridiculous introductory text. Unfortunately, there’s nothing better available “in a human model,” while the rat studies seem to be exceptional.

BPC-157 for Knee Pain - Poor Study

…. Knee pain is common and usually results from osteoarthritis, meniscus tears, tendon problems, or ligament injuries.

“`

Method

  • Retrospective analysis of 17 patients (16 reachable), injection directly into the knee joint (intra-articular), comparison: BPC-157 alone vs. BPC-157 + TB4
  • Assessment via telephone follow-up (pain reduction)

Results

    • BPC-157 alone:
      • 11 of 12 patients (91.6%) with significant improvement, 1 patient with no effect
    • BPC-157 + TB4:
      • 75% improvement, 25% without Effect
    • Total

:

  • 14 out of 16 patients (87.5%) benefited

The data show that intra-articular injection of BPC-157 often leads to significant improvement in various forms of knee pain.

https://asipp.org/wp-content/uploads/Intra-Articular-Injection-of-BPC-157-for-Multiple-Types-of-Knee-Pain-2021-Alternative-Therapies-in-Health-and-Medicine.pdf

Leaky Gut – My Own Experience from My Practice

A patient told me that he obtained capsules containing BPC-157 (illegally) and cured his years-long leaky gut with inflammatory bowel disease within two weeks. This isn’t a study, not real evidence, but at least it’s interesting—it was told by a real patient in my own practice. It’s an “anecdotal observation”—it has no official relevance.

Leaky Gut – My Own Experience from My Practice

A patient told me that he obtained capsules containing BPC-157 (illegally) and cured his years-long leaky gut with inflammatory bowel disease within two weeks.

BPC-157 and Alcohol – Repairs Stomach/Intestines – Reverses Alcohol-Induced Liver Damage (Rat Model)

Rats were subjected to chronic alcohol abuse, resulting in liver cirrhosis and damage to the gastrointestinal mucosa. These conditions were completely healed and reversed with BPC-157.

Rat Study with Alcohol and Liver/Stomach/Intestinal Damage

Experimental studies investigated whether the peptide BPC-157 can mitigate the harmful effects of alcohol on various organ systems. The focus was primarily on the liver, intestinal barrier, and central nervous system.

The results were completely healed and reversed with BPC-157.

are treated with alcohol chronically ill cirrhosis and gastrointestinal mucosal damage. It was then treated with BPC-157. are treated with BPC-157. It was then treated with BPC-157.

Key observations from animal models:

  • Acute mucosal damage in the gastrointestinal tract caused by high-proof alcohol was significantly reduced
  • The intestinal barrier (“leaky gut”) stabilized, resulting in fewer inflammatory processes
  • In chronic alcohol models, a regression of liver damage (e.g., inflammatory and degenerative changes) was observed
  • Evidence of neuroprotective effects, protecting nerve cells from alcohol-induced damage

A key concept here is the simultaneous effect on multiple systems:

    • Vascular protection and microcirculation
    • Stabilization of cell membranes
    • Promotion of regeneration and Healing Processes

In the scientific literature, BPC-157 has even been described in this context as a kind of functional antagonist of alcohol-related damage.

Data Context

The results are derived from a large number of preclinical studies, mostly in animal models, conducted over an extended period.

They consistently show that BPC-157:

      • can limit acute damage
      • partially reverses chronic changes
      • affects multiple organ systems simultaneously

Original Articles (Selection)

Some key publications from this research series:

Conclusion

The experimental data show that BPC-157 has a simultaneous protective and regenerative effect on several key organs in models of alcohol exposure.

The combination of the following is particularly striking:

Protection against acute damage

Support for tissue healing

Systemic effects on the intestines, liver, and brain

These results make BPC-157 one of the most interesting candidates in the field of regenerative medicine and tissue stabilization – also in the context of alcohol-related stress.

 

Impressive study results in rat eye injuries

The eyes of rats were perforated with a needle, and all rats went blind. However, the eyes of the rats that were given the “Wolferine” peptide BPC-157 regenerated.
Image

Eye injuries healed with BPC-157

Experimental animal studies investigated whether the peptide BPC-157 can improve the healing of tissue injuries. Studies on the cornea of ​​the eye are particularly impressive.

The cornea is normally avascular.This is essential for its transparency and therefore for vision. In the case of injury, the body often reacts with the growth of new blood vessels (neovascularization) to aid healing. However, these vessels often lead to clouding of the cornea and can permanently impair vision.

In the described animal experiments (rat model), the following was observed:

  • Following a targeted corneal injury, the untreated control group exhibited a typical healing response with neovascularization
  • This led to corneal opacity and functional visual impairment
  • In the group treated with BPC-157, however, the injury healed without significant neovascularization
  • The cornea remained clear and functional

These results are remarkable because they suggest that BPC-157 may support a more physiologically intelligent healing process—that is, wound closure without excessive repair reactions such as Vascular growth.

Important context

Despite these impressive experimental results, the following applies:

The data are predominantly derived from animal models (preclinical research).

There are no sufficient clinical studies on efficacy and safety in humans.

BPC-157 is not approved as a medicinal product in the EU.

It is listed by the World Anti-Doping Agency as a prohibited substance in sport.

Therefore, its use outside of clinical trials is medically and legally problematic.
… Sikiric et al., “Stable gastric pentadecapeptide BPC 157 improves corneal epithelial defects healing in rats” Link to the study (PubMed): https://pubmed.ncbi.nlm.nih.gov/17992677/

Conclusion

In preclinical models, BPC-157 demonstrates exceptional regenerative potential, particularly through healing without disruptive side effects such as angiogenesis.

However, robust data for clinical application in humans are currently lacking, so an evidence-based recommendation is not possible at this time.

 

Long-lasting bone lesion promptly eliminated by BPC-157

An 8mm hole is drilled into the bone of a live test rabbit; after 8 weeks, it is still present. Administration of BPC-157 leads to prompt healing.

details of this study

Long-lasting bone lesion promptly eliminated by BPC-157

An 8mm hole is drilled into the bone of a live test rabbit; after 8 weeks, it is still present.

Administration of BPC-157 leads to prompt healing.

  • HealthyAlfred highlights a 1999 rabbit study in his post, in which an 8 mm segmental bone defect in the radius did not heal in the control group after six weeks.
  • However, treatment with BPC-157 (locally or intramuscularly) resulted in bone regeneration comparable to autologous bone grafts or bone marrow transplants.
  • BPC-157, a 15-amino-acid peptide derived from human gastric juice, shows promising preclinical results for the repair of bones, tendons, and ligaments through angiogenesis, fibroblast activity, and the activation of Growth pathways.
  • Animal models report accelerated fracture healing without an identified toxic dose.
  • However, the evidence is currently limited to animal studies and small pilot studies in humans. BPC-157 is not approved for clinical use, large randomized trials are lacking, and it is usually only sold for research purposes.
This naturally explains why this peptide is on the doping list; no one wants to see injuries healed unethically quickly.

Presumably, all these animal studies are not applicable to humans.

 

Semax peptide can dramatically improve strokes when administered acutely.

Russian study on administering Semax in stroke patients

Semax is the most underrated nootropic peptide on the market.

Tweet from May 4, 2026, on X.com about a neurotropic peptide

https://x.com/morellifit/status/2051362103500615851?s=20

Michael Morelli (@morellifit), a performance optimization influencer with over 200,000 followers, shared a 13-part thread in which he described Semax as an underrated nootropic.ropikum, which has over 40 years of clinical use in Russia, is praised. He describes in detail its ACTH origin, rapid nasal absorption, BDNF upregulation, and positive effects on stroke rehabilitation.

The main findings are consistent with Russian studies, including a 2018 study of 110 patients with ischemic stroke, in which 6000 µg of Semax daily increased plasma BDNF levels and accelerated functional recovery.

In addition, there is data from rat studies showing an increase in BDNF in the hippocampus and serotonin modulation without dopamine spikes.

Semax is officially used in Russia for neuroprotection and cognitive problems, but in the West it remains a research chemical with few large-scale, independent studies.

At the end of the thread, Morelli promotes a specific nasal spray supplier and provides his discount code.

Peptide that Michael Morelli is promoting:

 https://www.realpeptides.co/products/semax-nasal-spray/ref/252/?el=x_5/4/26

= 10mg Semax in approximately 10ml of solution, where one spray is said to contain approximately 200µg Semax

Original study that Morelli refers to:

https://www.researchgate.net/publication/325375504_The_efficacy_of_semax_in_the_tretament_of_patients_at_different_stages_of_ischemic_stroke

 

Many of the tweets following the Morelli tweet above are interesting; several readers mention that they love SEMAX and that it quickly and powerfully clears their minds.

 

@HealthyAlfred – regularly posts peptide tweets

I would subscribe to him to stay informed about old and new studies on various peptides.

https://x.com/HealthyAlfred

 

AI Research on Neuro-Regenerative Peptides

Current pharmacological paradigms for Parkinson’s disease (PD) and Multiple Sclerosis (MS) are largely palliative or immunomodulatory, failing to address the underlying neuronal attrition or demyelination effectively. The “holy grail” of neurodegeneration research is the development of neurotropic (supporting survival) and neuroregenerative (inducing regrowth) peptides that can bypass the blood-brain barrier (BBB) and mimic the activity of large neurotrophins like Brain-Derived Neurotrophic Factor (BDNF).

Below is a rigorous screening of peptides with neuroregenerative potential, focused on their activity in BDNF pathways and their relevance to PD and MS.

1. BDNF Mimetics and Small Peptides

BDNF is the primary driver of neuronal survival and synaptic plasticity, but its therapeutic use is crippled by a 1-minute plasma half-life and its inability to cross the BBB (PLOS One, 2013). Small peptides that mimic the active loops of BDNF are the current frontier.

  • Peptides B-3 and B-5: These are synthetic tetra-peptides derived from the active regions of human BDNF.
    • Activity: They act as partial agonists for the TrkB receptor (the primary receptor for BDNF). Peptide B-5 has been shown to induce a positive feedback loop, increasing the expression of endogenous BDNF and TrkB (PLOS One, 2013).
    • Relevance: Primarily investigated for hippocampal survival, but the TrkB pathway is the central target for protecting dopaminergic neurons in PD.
  • 7,8-Dihydroxyflavone (7,8-DHF): While technically a flavonoid, it is often grouped with BDNF-mimetic research. It is a potent, BBB-permeable TrkB agonist that has shown neuroprotective effects in 6-OHDA-induced PD models.

2. Multi-Target Neurotropic Peptides

These peptides are often “cocktails” or derived from naturally occurring neuroprotective proteins.

  • Cerebrolysin: A porcine-derived peptide mixture that mimics the action of multiple neurotrophic factors (GDNF, BDNF, CNTF, and IGF-1).
    • Activity: It reduces oxidative stress, inhibits neuroinflammation, and promotes progenitor cell migration and neurogenesis (PMC10185619).
    • PD/MS Context: Clinical trials and animal models (reserpine and 6-OHDA) show it can restore dopamine levels and improve motor deficits (PMC10185619). It is currently one of the few peptide-based drugs used clinically in some jurisdictions for stroke and neurodegeneration (PubMed 26564102).
  • Semax (Met-Glu-His-Phe-Pro-Gly-Pro): A synthetic analog of ACTH(4-7) combined with a Pro-Gly-Pro tripeptide to increase stability.
    • Activity: It significantly increases the expression of BDNF and its receptor TrkB in the brain. It also modulates the expression of genes related to the immune response and vascular growth (PMC12755871).
    • PD/MS Context: Historically used for stroke recovery, recent research focuses on its ability to reverse cognitive decline and protect against amyloid-induced neurotoxicity (PMC12755871).

3. Peptides Targeting PD-Specific Pathways

  • HER-096 (C-CDNF Fragment): This is a small, BBB-permeable fragment of Cerebral Dopamine Neurotrophic Factor (CDNF).
    • Activity: Unlike GDNF, which primarily supports cell survival, CDNF/HER-096 acts on the endoplasmic reticulum (ER) stress response to prevent protein misfolding (e.g., alpha-synuclein).
    • PD Context: It is currently in Phase 1b clinical trials (as of late 2025/early 2026). Topline results indicate it is safe, tolerable, and reaches the brain in humans (Cure Parkinson’s).
  • GLP-1 Receptor Agonists (e.g., Exenatide, Semaglutide): While traditionally diabetes drugs, these are peptides that cross the BBB.
    • Activity: They activate GLP-1 receptors in the brain, which triggers downstream neuroprotective pathways similar to BDNF, including the PI3K/Akt pathway.
    • PD Context: Multiple clinical trials show GLP-1 agonists can restore dopamine levels and inhibit dopaminergic loss (PMC11011817).

4. Peptides Targeting MS and Demyelination

  • NAP (Davunetide / NAPVSIPQ): An 8-amino acid peptide derived from Activity-Dependent Neuroprotective Protein (ADNP).
    • Activity: It stabilizes microtubules by interacting with tubulin, which is critical for axonal transport. It also activates the PI3K/Akt and MAPK pathways (Current Pharmaceutical Design, 2011).
    • MS Context: Its ability to protect the “white matter” and reduce neuronal apoptosis makes it a candidate for both MS and tauopathies (Current Pharmaceutical Design, 2011).
  • CNTF Mimetics: Ciliary Neurotrophic Factor is a potent survival factor for oligodendrocytes (the cells that make myelin).
    • Activity: Small molecule or peptide mimetics of CNTF are being explored to induce remyelination in MS by promoting the differentiation of oligodendrocyte progenitor cells (PMC6425072).

Summary Table of Peptides

Peptide Primary Mechanism Target Disease Status (approx.)
Cerebrolysin Multi-neurotrophic mimicry PD, Stroke, AD Clinical Use (selected regions)
HER-096 ER stress / CDNF fragment Parkinson’s Phase 1b Clinical Trials
Semax BDNF/TrkB Up-regulation Stroke, AD, PD Clinical Use (Russia)
Exenatide GLP-1R Agonist Parkinson’s Phase 2/3 Clinical Trials
NAP (Davunetide) Microtubule stabilization MS, AD, PSP Research / Clinical Trials
B-5 Tetra-peptide TrkB Partial Agonist General Neuroregeneration Pre-clinical

Reference Links for Further Reading

  1. Cerebrolysin in PD Model (2023): PMC10185619
  2. BDNF Peptides and TrkB Activation: PLOS One Article
  3. Semax and Neuroprotection (2026): PMC12755871
  4. NAP (Davunetide) Review: Current Pharmaceutical Design
  5. Neuroregeneration in Parkinson’s (Review): PMC6425072
  6. GLP-1 Agonists in PD: PMC11011817

Confidence Level: High for mechanistic data; Moderate for clinical efficacy (as many are still in trial phases).

 

 

Superstars from the USA all use these peptides

Although it’s just as legally precarious in the USA, it seems easier to obtain peptides there.

WARNING: What you can buy online is almost always a scam. Genuine peptides should cost several hundred dollars.

 

Anti-Aging Star Dr. Andrew Huberman from the USA

This YouTube video from the Huberman Lab Podcast discusses the use of peptides and hormone therapies to improve health, performance, and longevity. Andrew Huberman speaks with Dr. Craig Koniver, an expert in performance medicine.

Anti-Aging Star Dr. Andrew Huberman from the USA

This YouTube video from the Huberman Lab Podcast discusses the use of peptides and hormone therapies to improve health, performance, and longevity. Here is a very brief summary of the main points:

 

  • What are peptides?: They are short chains of amino acids (small proteins) that trigger specific signals in the body [00:42].
  • GLP-1 (e.g., Ozempic/Mounjaro): Its use for weight loss is being discussed, with experts recommending microdosing (smaller doses) to minimize side effects such as muscle loss [11:07].
  • Healing and inflammation:
    • BPC-157: A well-known active ingredient for accelerating the healing of tendons, joints, and inflammation [19:46].
    • PDA (Pentadeca Arginate): Mentioned as a modern alternative to BPC-157 [43:28].
  • Growth Hormones & Sleep: Certain peptides such as Ipamorelin or Tesamorelin can stimulate the body’s own release of growth hormones, which can promote fat loss and better sleep [55:33].Sleep Optimization: The peptide Pinealone is described as very effective in significantly increasing REM sleep [1:28:01].NAD Therapy: High-dose NAD infusions or injections are considered a “game changer” for energy, focus, and Mitochondrial health highlighted [01:53:26].
  • Safety & Quality: Dr. Koniver strongly emphasizes that peptides should only be obtained through qualified physicians and compounding pharmacies.obtain them, as products from the black market are often contaminated [34:24].

 

The following video is from an interview with Andrew Huberman, in which he discusses various topics related to biohacking, health, and current trends. Here are the main points:

Peptides and Health

Peptides in general: Huberman explains that peptides are short chains of amino acids (e.g., insulin). He warns against obtaining peptides from the gray market (“Research Purposes Only”), as these can often contain impurities like LPS, which can trigger inflammation [10:43].

  • BPC-157: This peptide is often used for wound healing, although there is a lack of solid human data. It is said to have a systemic effect and promote tissue regeneration [11:41].
  • Pinealon: A peptide that Huberman himself has tried. It doubled his REM sleep time to almost three hours per night [12:35].
  • Retatrutide: He calls this peptide a “trillion-dollar drug”. It is a triple agonist (similar to Ozempic, but stronger) that led to weight loss of up to one-third of body weight in clinical trials [14:16].

 

Pharmacology and Sports

      • Tadalafil (Cialis): Huberman reports on the recommendation that men over 40 could consider a low daily dose (2.5 to 5 mg) to improve blood flow (brain, prostate) and lower blood pressure [06:30].
      • Performance Enhancement: He mentions that athletes often Using vasodilators or heart rate-lowering substances (in shooting sports) to increase composure and precision [08:05].

Lifestyle and Diet

      • Yerba Mate: Huberman is a co-owner of the brand Mateina. He drinks yerba mate for its steady caffeine release and antioxidant effects [00:21]. Studies suggest that caffeine can reduce the risk of dementia, but it should be used with caution in cases of anxiety [04:41].
      • Cannabis: He is critical of the high THC content of modern products. He states that young people with a genetic predisposition are at particularly high risk for psychosis. Furthermore, cannabis suppresses the important REM sleep [24:18].

Technology and Productivity

      • Social Media: He recommends limiting usage to a maximum of 45 to 90 minutes per day. His personal “hack” is a physical lockbox for his smartphone, in which it sits for 20+ hours a day [31:18].
      • AI (Artificial Intelligence): Huberman uses AI (specifically Claude) to test himself and consolidate knowledge (actively retrieving information) [35:21].

Personal

      • He lives in a converted art gallery and has an “analog room” in the basement without electronics, where he draws and prepares for podcasts [38:23].

 

 

 

Dave Aspray – AntiAging – Biohacker – Star from USA

https://www.youtube.com/results?search_query=dave+asprey+peptides

Gary Brecka – Anti-Aging / Best-Aging Star from the USA

In this video, Gary Brecka interviews six-time Mr. Olympia (Classic Physique) Chris Bumstead (Cbum). The conversation revolves around Cbum’s peptide stack, his supplementation, recovery protocols, and his mental strategies.

Here is a summary of the key points:

1. Peptide Stack & Tissue Healing

Chris Bumstead primarily uses peptides for injury recovery and to regulate his autoimmune kidney disease:

BPC-157 & TB-500: These are referred toGary Brecka calls it “a multivitamin for bodybuilders.” He uses it to heal tendon and joint injuries (e.g., his latissimus dorsi tear) [52:52].

  • Thymosin Alpha-1: He uses this peptide for immune modulation to control inflammatory responses to his autoimmune disease [55:42].
  • GHK-Cu (Copper Peptide): Discussed as a supplement for collagen production and skin/hair health [01:01:47].
  • Growth hormone peptides (CJC-1295, Ipamorelin): Brecka explains that these stimulate the body’s own production without closing the negative feedback loop, as synthetic HGH would [01:05:04].

 

2. Supplementation & Nutrition

Contrary to many expectations, Cbum uses a rather simple supplement regimen based on the basics:

Basics: Whey protein, creatine (5-10g daily), multivitamins, and glutamine for gut health [42:04], [43:57].

Cardiovascular Protection: He takes resveratrol, turmeric/curcumin, and bergamot to mitigate the negative effects of professional sports on cholesterol and organs. href=”http://www.youtube.com/watch?v=PfU449WFIOk&t=2815″>46:55], [47:31].

  • Quality: He places extreme value on the quality of food (e.g., grass-fed beef instead of fast food), which he sees as a key to his long-term success [19:47].

 

3. Health Challenges

  • Autoimmune Disease (2018): Four weeks before his first Olympic victory, Cbum ended up in the hospital with kidney problems and extreme edema. This experience taught him humility and forced him to adopt a less risky approach to bodybuilding [05:05].
  • Risk Management: After the illness, he partially halved his dosages of performance-enhancing drugs and set clear “guardrails” to avoid sacrificing his long-term health [16:39].

4. Mentality & Success

Discipline vs. Motivation: He emphasizes that systems and routine are more important than motivation. On days when he lacked energy, he focused solely on the next set or rep [01:14:31], [01:19:02].

Presence: In moments of victory on stage, he tried to be extremely present and let go of the fear of the outcome [01:21:44].

Chris Bumstead recently announced his retirement from professional sports and is now focusing on longevity and his family. [59:48].

 

several videos by Gary Breka on peptides

Google CENSORSHIP!

Google censors my homepage quite a bit, sometimes I am not even able to find my articles on Google. So please sign up for the newsletter and share it with friends or via Facebook and use the search function on my website. Follow me on Twitter, where I also announce important articles.